Awards in favour of Quantum BioPharma Total Approximately $3 Million TORONTO, ON / ACCESS Newswire / January 17, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (Upstream: QNTM ...

Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against ...

TORONTO, ON / ACCESSWIRE / January 14, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91)(Upstream:QNTM) ("Quantum BioPharma" or the "Company"), a ...

Nu ( NU 1.22%) stock jumped 28% in January according to data provided by S&P Global Market Intelligence. Nu announced several ...

Nu Holdings Ltd. NU has delivered impressive performance over the past month. Its stock has surged 30%, significantly outperforming the industry‘s growth of 6%. Considering the current strength ...

NU HOLDINGS LTD (NU) is a large-cap growth stock in the Money Center Banks industry. The rating using this strategy is 64% based on the firm’s underlying fundamentals and the stock’s valuation.

The company has captured 56% of the banking population in its home market. As it seeks to replicate its success elsewhere, ...

The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $15.63. NU has been the topic of several recent research reports. Susquehanna ...

Let's be clear: Nu is still a growth stock. The company's revenue grew 38% year over year in Q3 2024. Now, earnings are poised to follow suit. Nu turned profitable on a generally accepted ...

Nu Holdings' premium valuation is justified by efficient execution, robust growth prospects, and a scalable business model. The stock has a drawdown of -25% since its ATH even after gains of 17% ...